Fumihiko Kitagawa   Junnichi Ishii   Shinya Hiramitsu   Hiroshi Takahashi   Ryuunosuke Okuyama   Hideki Kawai   Takashi Muramatsu   Masahide Harada   Sadako Motoyama   Hiroyuki Naruse   Shigeru Matsui   Masayoshi Sarai   Mutsuharu Hayashi   Eiichi Watanabe   Hideo Izawa   Yukio Ozaki   
HEART AND VESSELS 32(5) 609-617 2017年5月 [査読有り]
Whether trough-phase rivaroxaban concentrations provide sufficient anticoagulation needs more study. We evaluated levels of coagulation activation markers in the trough concentration phase in nonvalvular atrial fibrillation (NVAF) patients, and th...